Status:
COMPLETED
Survey of Patients With Idiopathic Orbital Inflammation Syndrome
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Ministry of Health, France
Conditions:
Orbital Ischemic Syndrome
Orbital Pseudotumor
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to characterise the clinical features, histopathology and the treatment outcomes of patients with idiopathic orbital inflammation syndrome.
Detailed Description
Idiopathic orbital inflammatory syndrome (IOIS) is a heterogeneous group of disorders characterised by orbital inflammation without any identifiable local or systemic causes. It is a rare clinical ent...
Eligibility Criteria
Inclusion
- Patients with biopsy proven IOIS or presumed IOIS
- Patients with chronic IOS
- Patient with inaugural IOIS or being treated for IOIS
Exclusion
- Patients who do not fulfill the inclusion criteria
- Patients with systemic disease-associated IOIS
- Incomplete follow-up of patients treated for IOIS
Key Trial Info
Start Date :
March 3 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 3 2017
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT01443000
Start Date
March 3 2012
End Date
June 3 2017
Last Update
November 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Médecine interne - Hôpital Avicenne
Bobigny, France, 93000